(S)-colchicine increases expression EXP 6480464 Colchicine results in increased expression of TFPI2 mRNA CTD PMID:20624997 (S)-nicotine decreases expression ISO RGD:736798 6480464 Nicotine results in decreased expression of TFPI2 mRNA CTD PMID:12588870 (S)-nicotine increases expression ISO RGD:736798 6480464 Nicotine results in increased expression of TFPI2 mRNA CTD PMID:12588870 (S)-nicotine multiple interactions ISO RGD:736798 6480464 alpha-cobratoxin inhibits the reaction [Nicotine results in decreased expression of TFPI2 mRNA], Mecamylamine inhibits the reaction [Nicotine results in decreased expression of TFPI2 mRNA] CTD PMID:12588870 1,1-dichloroethene decreases expression ISO RGD:736799 6480464 vinylidene chloride results in decreased expression of TFPI2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:736799 6480464 1, 2-Dimethylhydrazine results in decreased expression of TFPI2 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of TFPI2 mRNA CTD PMID:25380136 17beta-estradiol increases expression ISO RGD:736798 6480464 Estradiol results in increased expression of TFPI2 mRNA CTD PMID:16202921 more ... 17beta-estradiol multiple interactions ISO RGD:736798 6480464 [Estradiol co-treated with Progesterone] results in increased expression of TFPI2 mRNA, [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of TFPI2 mRNA CTD PMID:19619570 , PMID:20660070 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:736798 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:736798 6480464 2 more ... CTD PMID:23146750 , PMID:31173147 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:736798 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of TFPI2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736798 6480464 Tetrachlorodibenzodioxin results in decreased expression of TFPI2 mRNA CTD PMID:19619570 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:736798 6480464 2 more ... CTD PMID:26705709 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:736798 6480464 3 more ... CTD PMID:29947894 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:736798 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TFPI2 mRNA more ... CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:736798 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TFPI2 mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression ISO RGD:736799 6480464 Fenretinide results in increased expression of TFPI2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine decreases methylation ISO RGD:736798 6480464 Decitabine results in decreased methylation of TFPI2 promoter CTD PMID:19435926 5-aza-2'-deoxycytidine multiple interactions ISO RGD:736798 6480464 [[Decitabine co-treated with trichostatin A] affects the methylation of TFPI2 promoter] which affects the expression of TFPI2 mRNA, [Decitabine co-treated with trichostatin A] affects the methylation of TFPI2 promoter CTD PMID:17464989 5-aza-2'-deoxycytidine increases expression ISO RGD:736798 6480464 Decitabine results in increased expression of TFPI2 mRNA CTD PMID:19435926 8-Br-cAMP increases expression ISO RGD:736798 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TFPI2 mRNA CTD PMID:20147733 , PMID:22079614 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of TFPI2 mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:736798 6480464 Aflatoxin B1 affects the expression of TFPI2 protein CTD PMID:20106945 all-trans-retinoic acid decreases expression ISO RGD:736798 6480464 Tretinoin results in decreased expression of TFPI2 mRNA CTD PMID:23724009 all-trans-retinoic acid increases expression ISO RGD:736798 6480464 Tretinoin results in increased expression of TFPI2 mRNA CTD PMID:21934132 , PMID:23830798 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of TFPI2 mRNA CTD PMID:16483693 amphibole asbestos increases expression ISO RGD:736798 6480464 Asbestos, Amphibole results in increased expression of TFPI2 mRNA CTD PMID:20831825 amphibole asbestos increases expression EXP 6480464 Asbestos, Amphibole results in increased expression of TFPI2 mRNA CTD PMID:22352330 aristolochic acid decreases expression ISO RGD:736798 6480464 aristolochic acid I results in decreased expression of TFPI2 mRNA CTD PMID:33212167 arsenite(3-) decreases expression ISO RGD:736798 6480464 arsenite results in decreased expression of TFPI2 mRNA CTD PMID:23974009 avobenzone increases expression ISO RGD:736798 6480464 avobenzone results in increased expression of TFPI2 mRNA CTD PMID:31016361 benzo[a]pyrene increases expression ISO RGD:736798 6480464 Benzo(a)pyrene results in increased expression of TFPI2 mRNA CTD PMID:17879257 more ... benzo[a]pyrene decreases methylation ISO RGD:736798 6480464 Benzo(a)pyrene results in decreased methylation of TFPI2 promoter CTD PMID:27901495 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:736799 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of TFPI2 mRNA] CTD PMID:19850644 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:736799 6480464 Diethylhexyl Phthalate results in decreased expression of TFPI2 mRNA CTD PMID:28085963 bis(2-ethylhexyl) phthalate increases expression ISO RGD:736799 6480464 Diethylhexyl Phthalate results in increased expression of TFPI2 mRNA CTD PMID:19850644 bisphenol A increases expression ISO RGD:736798 6480464 bisphenol A results in increased expression of TFPI2 mRNA CTD PMID:19371625 , PMID:31715268 bisphenol A increases methylation ISO RGD:736798 6480464 bisphenol A results in increased methylation of TFPI2 gene CTD PMID:28582417 bisphenol A multiple interactions ISO RGD:736798 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TFPI2 mRNA CTD PMID:28628672 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of TFPI2 mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:736798 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TFPI2 mRNA CTD PMID:28628672 carbamazepine affects expression ISO RGD:736798 6480464 Carbamazepine affects the expression of TFPI2 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:736799 6480464 Nanotubes, Carbon analog results in decreased expression of TFPI2 mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:736799 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carmustine affects response to substance ISO RGD:736798 6480464 TFPI2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 chloroprene decreases expression ISO RGD:736799 6480464 Chloroprene results in decreased expression of TFPI2 mRNA CTD PMID:23125180 cisplatin multiple interactions ISO RGD:736798 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of TFPI2 mRNA, [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of TFPI2 mRNA CTD PMID:27392435 , PMID:30871063 cisplatin decreases expression ISO RGD:736798 6480464 Cisplatin results in decreased expression of TFPI2 mRNA CTD PMID:27392435 clofibrate increases expression ISO RGD:736799 6480464 Clofibrate results in increased expression of TFPI2 mRNA CTD PMID:17585979 clofibrate multiple interactions ISO RGD:736799 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of TFPI2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TFPI2 mRNA] CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:736798 6480464 cobaltous chloride results in decreased expression of TFPI2 mRNA CTD PMID:19320972 , PMID:19376846 copper atom decreases expression ISO RGD:736798 6480464 Copper results in decreased expression of TFPI2 mRNA CTD PMID:19747488 copper(0) decreases expression ISO RGD:736798 6480464 Copper results in decreased expression of TFPI2 mRNA CTD PMID:19747488 copper(II) sulfate affects expression ISO RGD:736798 6480464 Copper Sulfate affects the expression of TFPI2 mRNA CTD PMID:19549813 crocidolite asbestos affects expression ISO RGD:736798 6480464 Asbestos, Crocidolite affects the expression of TFPI2 mRNA CTD PMID:25757056 crocidolite asbestos multiple interactions ISO RGD:736798 6480464 IL1RN protein inhibits the reaction [Asbestos more ... CTD PMID:28056339 crocidolite asbestos multiple interactions ISO RGD:736799 6480464 [CASP1 protein affects the susceptibility to Asbestos, Crocidolite] which affects the expression of TFPI2 protein CTD PMID:28056339 crocidolite asbestos increases secretion ISO RGD:736798 6480464 Asbestos, Crocidolite results in increased secretion of TFPI2 protein CTD PMID:28056339 crocidolite asbestos increases expression ISO RGD:736798 6480464 Asbestos, Crocidolite results in increased expression of TFPI2 mRNA CTD PMID:18687144 more ... cyclosporin A increases expression ISO RGD:736798 6480464 Cyclosporine results in increased expression of TFPI2 mRNA CTD PMID:20106945 dexamethasone decreases expression ISO RGD:736798 6480464 Dexamethasone results in decreased expression of TFPI2 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:736798 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TFPI2 mRNA more ... CTD PMID:28628672 dibenzo[a,l]pyrene increases expression ISO RGD:736798 6480464 dibenzo(a, l)pyrene results in increased expression of TFPI2 mRNA CTD PMID:15735009 dioxygen multiple interactions ISO RGD:736799 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TFPI2 mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of TFPI2 mRNA CTD PMID:33729688 dorsomorphin multiple interactions ISO RGD:736798 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:736798 6480464 TFPI2 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin decreases expression ISO RGD:736798 6480464 Doxorubicin results in decreased expression of TFPI2 mRNA CTD PMID:29803840 doxorubicin increases expression ISO RGD:736798 6480464 Doxorubicin results in increased expression of TFPI2 mRNA CTD PMID:30031762 endosulfan increases expression ISO RGD:736798 6480464 Endosulfan results in increased expression of TFPI2 mRNA CTD PMID:26615145 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of TFPI2 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:736798 6480464 entinostat results in increased expression of TFPI2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:736798 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA CTD PMID:27188386 etoposide affects response to substance ISO RGD:736798 6480464 TFPI2 protein affects the susceptibility to Etoposide CTD PMID:16217747 fonofos increases methylation ISO RGD:736798 6480464 Fonofos results in increased methylation of TFPI2 promoter CTD PMID:22847954 furan increases expression EXP 6480464 furan results in increased expression of TFPI2 mRNA CTD PMID:27387713 gold atom increases expression ISO RGD:736798 6480464 Gold results in increased expression of TFPI2 mRNA CTD PMID:29705079 gold(0) increases expression ISO RGD:736798 6480464 Gold results in increased expression of TFPI2 mRNA CTD PMID:29705079 indometacin multiple interactions ISO RGD:736798 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TFPI2 mRNA more ... CTD PMID:28628672 ivermectin decreases expression ISO RGD:736798 6480464 Ivermectin results in decreased expression of TFPI2 protein CTD PMID:32959892 lucanthone increases expression ISO RGD:736798 6480464 Lucanthone results in increased expression of TFPI2 mRNA CTD PMID:21148553 lycopene decreases expression ISO RGD:736798 6480464 lycopene results in decreased expression of TFPI2 mRNA CTD PMID:16886892 Mecamylamine multiple interactions ISO RGD:736798 6480464 Mecamylamine inhibits the reaction [Nicotine results in decreased expression of TFPI2 mRNA] CTD PMID:12588870 medroxyprogesterone acetate decreases expression ISO RGD:736798 6480464 Medroxyprogesterone Acetate results in decreased expression of TFPI2 mRNA CTD PMID:20843944 melphalan increases expression ISO RGD:736798 6480464 Melphalan results in increased expression of TFPI2 mRNA CTD PMID:22363485 mercury dibromide multiple interactions ISO RGD:736798 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA CTD PMID:27188386 methotrexate affects expression ISO RGD:736799 6480464 Methotrexate affects the expression of TFPI2 mRNA CTD PMID:18502557 methylisothiazolinone increases expression ISO RGD:736798 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of TFPI2 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:736798 6480464 methylmercuric chloride results in increased expression of TFPI2 mRNA CTD PMID:28001369 mitomycin C affects response to substance ISO RGD:736798 6480464 TFPI2 protein affects the susceptibility to Mitomycin CTD PMID:16217747 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of TFPI2 mRNA CTD PMID:25380136 nickel sulfate increases expression ISO RGD:736798 6480464 nickel sulfate results in increased expression of TFPI2 mRNA CTD PMID:22714537 nicotine multiple interactions ISO RGD:736798 6480464 alpha-cobratoxin inhibits the reaction [Nicotine results in decreased expression of TFPI2 mRNA], Mecamylamine inhibits the reaction [Nicotine results in decreased expression of TFPI2 mRNA] CTD PMID:12588870 nicotine increases expression ISO RGD:736798 6480464 Nicotine results in increased expression of TFPI2 mRNA CTD PMID:12588870 nicotine decreases expression ISO RGD:736798 6480464 Nicotine results in decreased expression of TFPI2 mRNA CTD PMID:12588870 O-methyleugenol increases expression ISO RGD:736798 6480464 methyleugenol results in increased expression of TFPI2 mRNA CTD PMID:32234424 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of TFPI2 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of TFPI2 mRNA CTD PMID:25729387 ozone decreases expression ISO RGD:736799 6480464 Ozone results in decreased expression of TFPI2 mRNA, Ozone results in decreased expression of TFPI2 protein CTD PMID:16183385 ozone increases expression EXP 6480464 Ozone results in increased expression of TFPI2 mRNA CTD PMID:26667333 ozone multiple interactions ISO RGD:736799 6480464 [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of TFPI2 mRNA, [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of TFPI2 mRNA CTD PMID:25658374 paclitaxel affects response to substance ISO RGD:736798 6480464 TFPI2 protein affects the susceptibility to Paclitaxel CTD PMID:16217747 panobinostat multiple interactions ISO RGD:736798 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:736798 6480464 panobinostat results in increased expression of TFPI2 mRNA CTD PMID:26272509 paracetamol multiple interactions ISO RGD:736799 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of TFPI2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TFPI2 mRNA] CTD PMID:17585979 paracetamol increases expression ISO RGD:736798 6480464 Acetaminophen results in increased expression of TFPI2 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol decreases expression ISO RGD:736799 6480464 Acetaminophen results in decreased expression of TFPI2 mRNA CTD PMID:11264010 paracetamol affects expression ISO RGD:736799 6480464 Acetaminophen affects the expression of TFPI2 mRNA CTD PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of TFPI2 mRNA CTD PMID:32680482 parathion increases methylation ISO RGD:736798 6480464 Parathion results in increased methylation of TFPI2 promoter CTD PMID:22847954 phenobarbital affects expression ISO RGD:736799 6480464 Phenobarbital affects the expression of TFPI2 mRNA CTD PMID:19136022 phenobarbital affects expression ISO RGD:736798 6480464 Phenobarbital affects the expression of TFPI2 mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:736798 6480464 Phenylmercuric Acetate results in increased expression of TFPI2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736798 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA CTD PMID:27188386 pirinixic acid affects expression ISO RGD:736799 6480464 pirinixic acid affects the expression of TFPI2 mRNA CTD PMID:19136022 pirinixic acid increases expression ISO RGD:736799 6480464 pirinixic acid results in increased expression of TFPI2 mRNA CTD PMID:17426115 more ... pirinixic acid multiple interactions ISO RGD:736799 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of TFPI2 mRNA] CTD PMID:20059764 pirinixic acid decreases expression ISO RGD:736799 6480464 pirinixic acid results in decreased expression of TFPI2 mRNA CTD PMID:18445702 prednisolone decreases expression ISO RGD:736798 6480464 Prednisolone results in decreased expression of TFPI2 mRNA CTD PMID:17379860 progesterone multiple interactions ISO RGD:736798 6480464 [Estradiol co-treated with Progesterone] results in increased expression of TFPI2 mRNA CTD PMID:20660070 progesterone increases expression ISO RGD:736798 6480464 Progesterone results in increased expression of TFPI2 mRNA CTD PMID:21795739 quercetin affects expression EXP 6480464 Quercetin affects the expression of TFPI2 mRNA CTD PMID:18178720 quercetin increases expression ISO RGD:736798 6480464 Quercetin results in increased expression of TFPI2 mRNA CTD PMID:21632981 resveratrol increases expression ISO RGD:736798 6480464 resveratrol results in increased expression of TFPI2 mRNA CTD PMID:19371625 , PMID:25888808 SB 431542 multiple interactions ISO RGD:736798 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Securinine increases expression ISO RGD:736798 6480464 securinine results in increased expression of TFPI2 mRNA CTD PMID:32662633 serpentine asbestos increases expression ISO RGD:736798 6480464 Asbestos, Serpentine results in increased expression of TFPI2 mRNA CTD PMID:24160326 silicon dioxide increases expression ISO RGD:736798 6480464 Silicon Dioxide analog results in increased expression of TFPI2 mRNA, Silicon Dioxide results in increased expression of TFPI2 mRNA CTD PMID:25351596 , PMID:25895662 sodium arsenite increases expression ISO RGD:736798 6480464 sodium arsenite results in increased expression of TFPI2 mRNA CTD PMID:22714537 sodium arsenite decreases expression ISO RGD:736798 6480464 sodium arsenite results in decreased expression of TFPI2 mRNA CTD PMID:34032870 sodium arsenite increases expression ISO RGD:736799 6480464 sodium arsenite results in increased expression of TFPI2 mRNA CTD PMID:16014739 sodium dodecyl sulfate increases expression ISO RGD:736798 6480464 Sodium Dodecyl Sulfate results in increased expression of TFPI2 mRNA CTD PMID:31734321 sunitinib decreases expression ISO RGD:736798 6480464 Sunitinib results in decreased expression of TFPI2 mRNA CTD PMID:31533062 temozolomide affects response to substance ISO RGD:736798 6480464 TFPI2 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 temozolomide decreases expression ISO RGD:736798 6480464 Temozolomide results in decreased expression of TFPI2 mRNA CTD PMID:31758290 terbufos increases methylation ISO RGD:736798 6480464 terbufos results in increased methylation of TFPI2 promoter CTD PMID:22847954 tert-butyl hydroperoxide increases expression ISO RGD:736798 6480464 tert-Butylhydroperoxide results in increased expression of TFPI2 mRNA CTD PMID:15336504 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of TFPI2 mRNA CTD PMID:21515302 testosterone decreases expression ISO RGD:736798 6480464 Testosterone results in decreased expression of TFPI2 mRNA CTD PMID:33359661 tetrachloromethane affects expression ISO RGD:736799 6480464 Carbon Tetrachloride affects the expression of TFPI2 mRNA CTD PMID:17484886 tetrachloromethane decreases expression ISO RGD:736799 6480464 Carbon Tetrachloride results in decreased expression of TFPI2 mRNA CTD PMID:27339419 , PMID:31919559 tetraphene decreases expression ISO RGD:736799 6480464 benz(a)anthracene results in decreased expression of TFPI2 mRNA CTD PMID:26377693 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of TFPI2 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of TFPI2 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of TFPI2 mRNA CTD PMID:25729387 topotecan affects response to substance ISO RGD:736798 6480464 TFPI2 protein affects the susceptibility to Topotecan CTD PMID:16217747 trichostatin A multiple interactions ISO RGD:736798 6480464 [[decitabine co-treated with trichostatin A] affects the methylation of TFPI2 promoter] which affects the expression of TFPI2 mRNA, [decitabine co-treated with trichostatin A] affects the methylation of TFPI2 promoter CTD PMID:17464989 trichostatin A increases expression ISO RGD:736798 6480464 trichostatin A results in increased expression of TFPI2 mRNA CTD PMID:24935251 , PMID:26272509 triclosan decreases expression ISO RGD:736798 6480464 Triclosan results in decreased expression of TFPI2 mRNA CTD PMID:30510588 urethane increases expression ISO RGD:736798 6480464 Urethane results in increased expression of TFPI2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:736799 6480464 Valproic Acid affects the expression of TFPI2 mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:736798 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:736798 6480464 Valproic Acid results in increased expression of TFPI2 mRNA CTD PMID:23179753 more ... vincaleukoblastine affects response to substance ISO RGD:736798 6480464 TFPI2 protein affects the susceptibility to Vinblastine CTD PMID:16217747 vincaleukoblastine increases expression EXP 6480464 Vinblastine results in increased expression of TFPI2 mRNA CTD PMID:20624997 vorinostat increases expression ISO RGD:736798 6480464 vorinostat results in increased expression of TFPI2 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:736798 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFPI2 mRNA CTD PMID:27188386 zinc atom increases expression ISO RGD:736798 6480464 Zinc results in increased expression of TFPI2 mRNA CTD PMID:16870260 zinc dichloride increases expression ISO RGD:736798 6480464 zinc chloride results in increased expression of TFPI2 mRNA CTD PMID:16870260 zinc(0) increases expression ISO RGD:736798 6480464 Zinc results in increased expression of TFPI2 mRNA CTD PMID:16870260 zoledronic acid increases expression ISO RGD:736798 6480464 zoledronic acid results in increased expression of TFPI2 mRNA CTD PMID:24714768
